Tag Archives: secondary care

Introduction Heart failure (HF) is a clinical syndrome due to a structural or functional abnormality of the heart that results in elevated intracardiac pressure or inadequate cardiac output at rest or during exercise.1 It affects around 900,000 people in the UK and poses a significant burden on the National Health Service (NHS), accounting for one million bed days per year.2 HF reduces life-expectancy with a one-year survival rate of 75.9% post-diagnosis and a 10-year survival of 24.5%.3 Patients living with HF also suffer from disability and reduced quality of life.4 With an ageing population, greater survival from myocardial infarctions (MI

Introduction to the steering committee From left to right: Professor Martin Cowie, Dr Matthew Fay, Ms Jo Jerrome,Dr Abhishek Joshi, Dr Jim Moore, Ms Helen Williams Conflicts of interest The steering committe received speaking and consultation fees from Bayer plc. MRC provides consultancy advice to Abbott, AstraZeneca, Bayer, Boston Scientific, Medtronic, Novartis, Roche Diagnostics and Servier. MF has received speaker honoraria, conference sponsorship, unrestricted educational grants, and/or attended meetings sponsored by AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Medtronic, Novartis, Pfizer, Roche, Sanofi-Aventis, and S

No content available

No content available